Search
Filter Results
Displaying 61–70 of 319 results for “stem-cells”
-
Oct 15, 2012
Nobel Prize Winners Have Big Impact on Emerging Retinal Treatments
The 2012 Nobel Medicine prize winners are having an enormous impact on sight-saving retinal research.
-
Apr 22, 2022
Foundation Summit Highlights Robust Growth in Commercial Development for Retinal Disease Therapies
The Foundation’s Investing in Cures Summit (ICS), held on April 2, 2022, in Half Moon Bay, California, convened 175 researchers, industry executives, and constituents to present and discuss the expanding and accelerating commercial development of emerging therapies for retinal degenerative diseases.
-
Jun 12, 2012
Could Combining Future Treatments Be an Option?
How therapies will likely be used synergistically in the future.
-
Apr 30, 2024
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Apr 16, 2018
Retinal Patch Performs Promisingly in Clinical Trial for Dry AMD Patients
Regenerative Patch Technologies, a company developing stem-cell-derived treatments for people with retinal diseases, has reported encouraging results for the first five patients with advanced, dry age-related macular degeneration (AMD) participating in a Phase I/IIa clinical trial for its therapy – a patch comprised of a layer of retinal pigment epithelial (RPE) cells on a synthetic scaffold.
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2020 (July 1, 2019-June 30, 2020)
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2021 (July 1, 2020–June 30, 2021)
-
Virtual Workshop on Inflammation in Viral Gene Therapy of the Retina
This workshop was designed to bring together industry and academia to discuss openly what is known about the interactions of viral-mediated gene therapy of the retina with the immune system and the clinical consequences of that.
-
Apr 3, 2024
Recording Available: Foundation Insights Forum – March 20, 2024
The Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on March 20, 2024.
-
Apr 28, 2023
Dr. Tucker is leading the development of GMP facilities for manufacturing clinical grade retinal therapies